Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation

Transplant International

Volumn 13, Issue SUPPL. 1, 2000, Pages

  Seehofer, D ^a   Rayes, N ^a   Neuhaus, R ^a   Berg, T ^a   Muller A R ^a   Bechstein, W O ^a   Neuhaus, P ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Combination therapy; Hepatitis B; Interferon; Lamivudine; Liver transplantation; Resistance

Indexed keywords

2 AMINOPURINE; ALANINE AMINOTRANSFERASE; ALPHA2A INTERFERON; ANTIVIRUS AGENT; DRUG DERIVATIVE; FAMCICLOVIR; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; VIRUS DNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD; DRUG COMBINATION; DRUG EFFECT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER TRANSPLANTATION; MIDDLE AGED; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; RETROSPECTIVE STUDY; TIME; VIRUS REPLICATION;

2-AMINOPURINE; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; DNA, VIRAL; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON ALFA-2A; LAMIVUDINE; LIVER TRANSPLANTATION; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; VIRUS REPLICATION;

EID: 0000063059     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2000.tb02060.x     Document Type: Article

References (12)

1. Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE (1991) Orthotopic liver transplantation for patients with hepatitis B virus related liver disease. Hepatology 13: 619-626
2. Samuel D, Muller R, Alesander G, et al (1993) Liver transplantation in European patients with hepatitis B surface antigen. N Engl J Med 329: 1842-1847
3. Bartholomew MM, Jansen RW, Jeffers LL, et al (1997) Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 349: 20-22
4. Zoulim F, Trépo C (1998) Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy. J Hepatol 29: 151-168
5. Larder BA, Kempt SH, Harrigan RP (1995) Potential mechanisms for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science 269: 696-699
6. Colledge D, Locarnini S, Shaw T (1997) Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro. Hepatology 26: 216-225
7. Mutimer D, Naoumov N, Honkoop P, Marinos G, Ahmed M, de Man R, McPhillips P, Johnson M, Williams R, Elias E, Schalm S (1998) Combination alpha interferon and lamivudine therapy for alpha interferon resistant chronic hepatitis B infection: results of a pilot study. J Hepatol 28: 923-929
8. Wong DKH, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J (1993) Effect of alpha-interferon treatment in patients with hepatitis B e-antigen positive chronic hepatitis B: a meta analysis. Ann Intern Med 119: 312-323
9. Neuhaus P, Steffen R, Blumhard G, Bechstein W, Keck H, Lemmens HP, Neuhaus R, Lobeck H, König V, Hopf U (1991) Experience with immunoprophylaxis and interferon therapy after liver transplantation in HBsAG-positive patients. Transplant Proc 23: 1522-1524
10. Rakela J, Wooten R, Batt SK, Perkins JD, Taswell HF, Krom RAF (1989) Failure of interferon to prevent recurrent hepatitis B infection in hepatic allograft. Mayo Clin Proc 64: 429-432
11. Hopf U, Neuhaus P, Lobeck H, König V, Küther S et al (1991) Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-α. J Hepatol 13: 339-346
12. Terrault NA, Holland CC, Ferrell L, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL (1996) Interferon alpha for recurrent hepatitis B infection after liver transplantation. Liver Transplant Surg 2: 132-138